We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+1.33%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$331M
AUM Growth
-$113M
Cap. Flow
-$103M
Cap. Flow %
-31.27%
Top 10 Hldgs %
56.38%
Holding
49
New
6
Increased
7
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$6.98M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$5.79M
3
MDU icon
MDU Resources
MDU
+$5.1M
4
RCM
R1 RCM Inc. Common Stock
RCM
+$4.3M
5
STAA icon
STAAR Surgical
STAA
+$3.98M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$25.9M
2
CLVT icon
Clarivate
CLVT
+$22.7M
3
AZN icon
AstraZeneca
AZN
+$14M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.58M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.56M

Sector Composition

Rank Sector Weight
1 Healthcare 39.32%
2 Technology 21.77%
3 Financials 11.08%
4 Communication Services 6.26%
5 Consumer Staples 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
1
Uber
UBER
$143B
$33M 9.99%
1,246,009
+252,700
+25% +$6.98M
MS icon
2
Morgan Stanley
MS
$332B
$27M 8.18%
342,214
– –
GDDY icon
3
GoDaddy
GDDY
$10.2B
$25.8M 7.81%
364,353
-81,600
-18% -$6.14M
CHTR icon
4
Charter Communications
CHTR
$16.7B
$20.7M 6.26%
68,159
– –
ALC icon
5
Alcon
ALC
$33.7B
$15.7M 4.75%
269,892
-43,223
-14% -$3M
IRTC icon
6
iRhythm Holdings
IRTC
$3.83B
$15.1M 4.58%
120,879
+1,100
+0.9% +$159K
CZR icon
7
Caesars Entertainment
CZR
$6.04B
$13.3M 4.02%
411,753
– –
TEVA icon
8
Teva Pharmaceuticals
TEVA
$40.8B
$12.1M 3.66%
1,500,000
– –
PSPC.U
9
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
$12.1M 3.65%
1,250,000
– –
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$120B
$11.5M 3.48%
39,772
-33,300
-46% -$9.58M
HUM icon
11
Humana
HUM
$44.3B
$10.2M 3.08%
21,000
-14,000
-40% -$6.81M
AVAN.U
12
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
$10M 3.03%
1,000,000
– –
WRAC
13
DELISTED
Williams Rowland Acquisition Corp.
WRAC
$9.58M 2.9%
950,000
– –
IRWD icon
14
Ironwood Pharmaceuticals
IRWD
$644M
$9.49M 2.87%
916,314
-39,700
-4% -$450K
AZN icon
15
AstraZeneca
AZN
$263B
$8.58M 2.6%
78,200
-110,100
-58% -$14M
BMRN icon
16
BioMarin Pharmaceuticals
BMRN
$11.7B
$8.51M 2.58%
100,400
-107,400
-52% -$9.56M
AIRS icon
17
AirSculpt Technologies
AIRS
$340M
$8.35M 2.53%
1,298,141
-336,800
-21% -$2.71M
POST icon
18
Post Holdings
POST
$4.18B
$8.21M 2.49%
100,298
– –
VRSN icon
19
VeriSign
VRSN
$25.5B
$8.16M 2.47%
46,953
-46,800
-50% -$8.66M
RCM
20
DELISTED
R1 RCM Inc. Common Stock
RCM
$6.95M 2.1%
374,800
+188,800
+102% +$4.3M
KRTX
21
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.43M 1.95%
+28,600
New +$5.79M
SKIN icon
22
SkinHealth Systems
SKIN
$95.3M
$5.26M 1.59%
446,607
-648,103
-59% -$8.19M
SOC icon
23
Sable Offshore Corp
SOC
$884M
$4.92M 1.49%
500,000
– –
MDU icon
24
MDU Resources
MDU
$4.18B
$4.8M 1.45%
+461,545
New +$5.1M
DCBO
25
Docebo
DCBO
$528M
$4.08M 1.23%
150,300
– –
1
2

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridger Management held 49 positions worth $331M, down 25% from $444M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Bridger Management withdrew a net $103M in Q3 2022, closing 5 positions and reducing 16 holdings. Its most notable exit was Clarivate, an estimated $22.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 46% a quarter earlier, followed by Technology and Financials.

Against the trend, Bridger Management opened a new position in Karuna Therapeutics, Inc. Common Stock worth $6.43M.

  • Bridger Management's largest Q3 2022 buy was Karuna Therapeutics, Inc. Common Stock: 28,600 shares worth $6.43M.
  • Bridger Management added most to Uber in Q3 2022, an estimated $6.98M increase.
  • Bridger Management's biggest Q3 2022 reduction was Centene, cutting an estimated $25.9M.
  • Bridger Management fully exited Clarivate in Q3 2022, selling an estimated $22.7M.
  • Bridger Management's ten largest holdings make up 56% of its $331M portfolio in Q3 2022.
  • Bridger Management opened 6 new positions and closed 5 in Q3 2022.
  • Bridger Management's portfolio value fell 25% quarter-over-quarter to $331M.

Based on Bridger Management's 13F filing for Q3 2022, filed 14 Nov 2022.